Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.397 | The Dreamcatchers Programme – A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients: A Pilot Randomized Controlled Trial | Miss Mak Shuk Yan |
| 2025.405 | Retrospective collection of TEE image with corresponding X-ray/CT/MR images and data, for Development Next-generation AI-XR Empowered Surgical Planning and Intraoperative Guidance System via Effective Fusion of Empirical Knowledge, Human Interaction, and Machine Inference. | Prof. LEE Pui Wai |
| 2025.386 | A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012) | Prof. MA Brigette Buig Yue |
| 2025.385 | A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2025.423 | Examining the association between senior badminton athlete’s training routine, physical fitness, and injury incidence |
Dr. NG Johan 吳又言 |
| 2025.416 | Prospective Multi-Centre Randomised Controlled Trial on the Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair | Dr. LING Samuel |
| 2025.413 | Identification of trauma-induced coagulopathy in severely injured patients using logistic regression based and machine learning models: An ambispective cohort study using a 10-year trauma registry in Hong Kong | Prof. HUNG Kevin Kei Ching |
| 2025.417 | Optimal acute adult psychiatric in-patient care in Hong Kong: a mixed-method study | Ms. CHUNG Sui Mei |
| 2025.431 | Mental health trajectories and influencing factors among physical trauma patients in Hong Kong: a prospective longitudinal study | Prof. HUNG Kevin Kei Ching |
| 2025.378 | Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study | Dr. CHEUNG Kitty Kit Ting |
| 2025.377 | Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study | Dr. TSANG Chiu Chi |
| 2025.376 | Outcomes of patients with adrenocortical carcinoma in Hong Kong: a territory-wide study | Dr. WONG I Ming |
| 2025.404 | Oral microbiome as a non-invasive diagnostic for early detection of colorectal neoplasia | Prof. YU Jun |
| 2025.403 | Integrated metabolomic and metagenomic biomarkers for early colorectal neoplasia diagnosis across diverse patient populations | Prof. YU Jun |
| 2025.384 | Training programme for young adult community health advisor (YACHA)- led project to promote anti-drug awareness among South Asian youths and their family in Hong Kong | Dr. CHAN Dorothy N.S. |
| 2025.392 | PWH Spine Registry | Dr. LAU Cyrus Tsun Kit |
| 2025.382 | A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q | Prof. NG Margaret Heung Ling |
| 2025.402 | Surgical accuracy of open platform image‐based robotic‐assisted total hip arthroplasty | Prof. ONG Michael Tim Yun |
| 2025.371 | A Case-Control Study to Identify Risk Factors for Catheter fracture of Implanted Venous Access Port in the Oncology Department |
Ms. MAK So Shan 麥素珊 |
| 2025.393 | Effects of dance-based multimodal exercise programme for managing chemotherapy-induced peripheral neuropathy in patients with colorectal cancer: A randomized controlled study | Ms. LAU Ka Yan |
| 2025.390 | Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial | Dr. CHONG Kelvin Kam Lung |
| 2025.389 | Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial | Dr. WU Anson Chun Long |
| 2025.401 | Adapting the CORN Intraoperative-Acquired Pressure Injury Risk Assessment Scale to Operative Settings in Hong Kong | Dr. CHAN Dorothy NS |
| 2025.436 | The Effects of artificial intelligence- based chatbot "NeuroBot" for improving anxiety of patients undergoing neurovascular surgeries: a randomised controlled trial | Ms. HO Chung Man |
| 2025.388 | CCCG-ALL 2025 Intermediate- and high-risk B-cell acute lymphoblastic leukemia |
Prof. LI Chi Kong Chi Kong LI |
| 2025.400 | Surgical accuracy of open platform image‐based robotic‐assisted total knee arthroplasty across different implants: a multicentre trial | Prof. ONG Michael Tim Yun |
| 2025.391 | Using Radiation-free Ultrasound for Screening Scoliosis Among School Children in Hong Kong to Reduce Unnecessary X-ray Exposure | Dr. KWAN Cheuk Kin |
| 2025.372 | A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects with Chronic Hepatitis B Virus Infection (B-SUPREME) | Prof. WONG Grace Lai Hung |
| 2025.370 | Understanding the disease burden and improving the long-term outcomes of childhood-onset nephrotic syndrome through big data analytics | Prof. CHAN Yu Hin |
| 2025.365 | A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Platinum-based Chemotherapy in Combination with Pembrolizumab, as First-line Therapy in Participants with Locally Advanced Unresectable or Metastatic HER2 overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06) | Dr. LOONG Herbert Ho Fung |
| 2025.374 | MUSCLE-ML: Multimodal integration of muscle strength, structure by Machine Learning for Precision Rehabilitation After ACL Injury |
Prof. YUNG Patrick Shu Hang 容樹恒 |
| 2025.367 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. TANG Hoi San 鄧凱珊 |
| 2025.368 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. TAM Lydia Ho Pui 譚皓珮 |
| 2025.369 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. HO Ling Yin 何令妍 |
| 2025.495 | Comparison of clinical, pathological, immunological, and prognostic characteristics in patients with metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and hepatitis B virus-related hepatocellular carcinoma who underwent hepatectomy: a multicenter study |
Dr. WONG Vincent 黃煒燊 |
| 2025.373 | A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer | Prof. YEO Winnie |
| 2025.381 | A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q | Dr. CHEUNG Joyce Sin |
| 2025.580 | Retrospective Review of Post-Irradiated Nasopharyngeal Carcinoma Patients with Osteoradionecrosis of the Nasopharynx |
Dr. LIAO Christopher Man Ka YEUNG |
| 2025.364 | A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) | Prof. HUI David Shu Cheong |
| 2025.363 | Epidemiological analytics in the realm of big data for the enhancement of the understanding of orthopaedic conditions | Prof. LUI Pauline Po Yee |
| 2025.361 | Medication adherence patterns and treatment beliefs of patients using proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) | Dr. TSANG Chiu Chi |
| 2025.360 | Establishment of New Territories East Cluster Biliary Tract Cancer Database | Prof. CHAN Stephen Lam |
| 2025.395 | An Automatic Surgical Planning Assistant for Reverse Shoulder Arthroplasty Using Large Language Models |
Prof. CHUI Elvis Chun Sing Elvis Chun-Sing Chui |
| 2025.375 | tReatment Individualisation By EBV stratificatiON in nasopharyngeal carcinoma: an umbrella platform study (RIBBON-Umbrella) | Prof. MA Brigette Buig Yue |
| 2025.379 | Exploring the relationship between perceived stress, resilience level and coping skills among student midwives: A sequential mixed-methods design |
Prof. LAU Ying 劉櫻 |
| 2025.346 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Dr. TANG Hoi San 鄧凱珊 |
| 2025.345 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Prof. SO Ho 蘇皓 |
| 2025.344 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Dr. HO Ling Yin 何令妍 |
| 2025.348 | Understanding Mental Health Screening for Caregivers of Children with Developmental Concerns: Perspectives and Barriers Among Caregivers and Healthcare Providers Across Global Contexts | Dr. WONG Wing Ho |
| 2025.444 | Clinical utility of cerebrospinal fluid cell-free DNA/RNA for diagnosis of leptomeningeal metastasis of non-small cell lung cancer | Dr. LEUNG Joyce May Sum |
Page 6 of 272.